ACADIA Pharmaceuticals Reports $342.3M in Third-Quarter Revenue
Valid market news retained in the public archive without immediate LiveCast distribution.
Story updates
09:08:38 PM UTC
SquawkNews
Q3 2026 revenue rose 23% to $342M from $279M a year earlier. Net income fell to $54M, or $0.31 per diluted share, from $72M, or $0.42.Material DetailsContext by AI AnalystThis is a quarterly operating update showing continued commercial growth alongside lower year-over-year net income. Revised 2026…